Autonomic Nervous System Drugs Practice Questions

Q: Which of the following drugs binds only with the anionic site of cholinesterase?

Edrophonium. ### Explanation The enzyme **Acetylcholinesterase (AChE)** possesses two primary binding domains: the **anionic site** (which attracts the positive quaternary ammonium group of acetylcholine) and the **esteratic site** (where the actual hydrolysis occurs). #### Why Edrophonium is Correct **Edrophonium** is a quaternary ammonium compound that binds **reversibly and non-covalently** only to the **anionic site** of the enzyme via electrostatic attraction. Because it does not form a covalent bond with the esteratic site, its binding is very weak and short-lived. This explains its rapid onset and very short duration of action (5–15 minutes). #### Why Other Options are Incorrect * **Physostigmine, Neostigmine, and Pyridostigmine** are **Carbamates**. These drugs are "substrate substitutes." They bind to **both the anionic and the esteratic sites**. * Unlike Edrophonium, they covalently transfer a carbamoyl group to the esteratic site (carbamoylation). This bond is much more stable than the simple ionic attraction of Edrophonium, leading to a longer duration of action (0.5 to 6 hours). * **Physostigmine** is a tertiary amine (crosses BBB), while **Neostigmine** and **Pyridostigmine** are quaternary amines (do not cross BBB). #### NEET-PG High-Yield Pearls * **Tensilon Test:** Edrophonium was historically used to diagnose Myasthenia Gravis (MG) due to its rapid action. A brief improvement in muscle strength indicates a positive test. * **Differentiation:** It is also used to differentiate between a **Myasthenic crisis** (improvement with Edrophonium) and a **Cholinergic crisis** (worsening with Edrophonium). * **Drug of Choice:** Pyridostigmine is the DOC for the long-term oral treatment of Myasthenia Gravis. * **Antidote:** Physostigmine is the specific antidote for Atropine (anticholinergic) poisoning.

Q: Which of the following drugs does not cross the blood-brain barrier?

Glycopyrrolate. **Explanation:** The ability of a drug to cross the blood-brain barrier (BBB) is primarily determined by its chemical structure—specifically, whether it is a **quaternary ammonium compound** or a **tertiary amine**. **1. Why Glycopyrrolate is the correct answer:** Glycopyrrolate is a **quaternary ammonium compound**. These molecules are permanently charged (ionized) at physiological pH and are highly polar. Because the BBB is a lipid-rich membrane, polar/ionized drugs cannot diffuse across it. Therefore, Glycopyrrolate lacks central nervous system (CNS) side effects, making it ideal for reducing secretions pre-operatively without causing sedation or cognitive impairment. **2. Why the other options are incorrect:** * **Atropine & Scopolamine:** These are **tertiary amines**. They are non-ionized and lipid-soluble, allowing them to cross the BBB easily. Scopolamine, in particular, has significant CNS effects (sedation, amnesia) and is used for motion sickness. * **Promethazine:** This is a first-generation H1-antihistamine with strong anticholinergic properties. It is highly lipophilic and crosses the BBB readily, which is why it causes significant sedation. **Clinical Pearls for NEET-PG:** * **Mnemonic:** "Quaternary stays in the Quarters" (does not cross BBB). Examples: Glycopyrrolate, Ipratropium, Tiotropium, Neostigmine. * **Physostigmine vs. Neostigmine:** This is a classic comparison. Physostigmine (Tertiary) crosses the BBB and is used to treat Atropine toxicity. Neostigmine (Quaternary) does not cross the BBB. * **Clinical Choice:** Glycopyrrolate is preferred over Atropine in anesthesia when only peripheral muscarinic blockade is desired (e.g., to prevent bradycardia during reversal of neuromuscular blockade).

Q: Which of the following is NOT an alpha-adrenoceptor agonist?

Isoxsuprine. **Explanation:** The correct answer is **Isoxsuprine** because it is a **selective Beta-2 (β₂) adrenoceptor agonist**, not an alpha-agonist. It also possesses some direct vasodilator properties. **1. Why Isoxsuprine is the correct answer:** Isoxsuprine acts primarily on β₂ receptors in the smooth muscles of blood vessels and the uterus. Historically, it was used as a **tocolytic** (to delay premature labor) and a peripheral vasodilator. Since the question asks for the drug that is *NOT* an alpha-agonist, Isoxsuprine fits the criteria. **2. Analysis of incorrect options (Alpha-agonists):** * **Clonidine:** A prototypical **selective Alpha-2 (α₂) agonist**. It acts centrally to decrease sympathetic outflow, used primarily in hypertension and opioid withdrawal. * **Methyldopa:** A centrally acting **Alpha-2 (α₂) agonist**. It is a prodrug converted to α-methylnorepinephrine, which stimulates central α₂ receptors. It is the drug of choice for hypertension in pregnancy. * **Guanabenz:** Similar to clonidine, it is a **selective Alpha-2 (α₂) agonist** used for antihypertensive therapy. **High-Yield Clinical Pearls for NEET-PG:** * **Central α₂ Agonists:** Clonidine, Methyldopa, Guanfacine, and Guanabenz. They are used to treat hypertension by reducing central sympathetic tone. * **Tocolytics Mnemonic:** "It's Not My Time" (**I**ndomethacin, **N**ifedipine, **M**agnesium sulfate, **T**erbutaline/Ritodrine/Isoxsuprine). * **Isoxsuprine** is now less commonly used as a tocolytic due to the preference for more selective agents like Nifedipine or Atosiban. * **Methyldopa Side Effect:** Positive Coombs test (autoimmune hemolytic anemia).

Q: Which of the following is a long-acting non-depolarizing competitive blocker?

Doxacurium. **Explanation:** Neuromuscular blockers (NMBs) are classified based on their mechanism of action and duration of effect. Non-depolarizing blockers act as competitive antagonists at the nicotinic receptors ($N_m$) of the neuromuscular junction. **1. Why Doxacurium is correct:** Doxacurium belongs to the **Benzylisoquinolinium** class. It is characterized as a **long-acting** agent with a duration of action typically exceeding 60–90 minutes. It is highly potent and lacks significant cardiovascular side effects (no histamine release), making it suitable for long surgical procedures. **2. Why the other options are incorrect:** * **Rocuronium:** This is an **intermediate-acting** steroid-based NMB. It is notable for its rapid onset of action, making it the preferred alternative to Succinylcholine for Rapid Sequence Induction (RSI). * **Mivacurium:** This is a **short-acting** benzylisoquinolinium. It is unique because it is metabolized by plasma cholinesterase (like Succinylcholine), leading to a brief duration of action (approx. 15–20 mins). * **Atracurium:** This is an **intermediate-acting** agent. It is famous for undergoing **Hofmann Elimination** (spontaneous non-enzymatic degradation), making it safe for patients with liver or kidney failure. **High-Yield Clinical Pearls for NEET-PG:** * **Longest acting NMB:** Pancuronium or Doxacurium. * **Shortest acting Non-depolarizing NMB:** Mivacurium. * **Drug of choice in Renal/Hepatic failure:** Atracurium or Cisatracurium (due to Hofmann elimination). * **Laudanosine Toxicity:** A metabolite of Atracurium that can cross the BBB and cause seizures. * **Reversal Agent:** Sugammadex is specifically used to reverse "onium" drugs (Rocuronium > Vecuronium).

Q: Which of the following is a relatively cerebroselective anticholinesterase found to afford symptomatic improvement in Alzheimer's disease?

Donepezil. ### Explanation **Correct Option: A. Donepezil** Alzheimer’s disease is characterized by a cholinergic deficiency in the brain. **Donepezil** is a reversible, long-acting, and **relatively cerebroselective** (central-acting) acetylcholinesterase (AChE) inhibitor. Its high affinity for AChE in the brain compared to the periphery minimizes systemic side effects. By inhibiting the breakdown of acetylcholine in the synaptic cleft, it enhances cholinergic transmission, providing symptomatic improvement in cognitive function. Other drugs in this class include Rivastigmine and Galantamine. **Analysis of Incorrect Options:** * **B. Pyridostigmine:** This is a quaternary ammonium compound that does not cross the blood-brain barrier (BBB). It is used primarily for **Myasthenia Gravis** to act on the nicotinic receptors at the neuromuscular junction. * **C. Pyritinol:** Also known as Pyrithioxine, it is a semi-synthetic water-soluble analog of Vitamin B6. It is classified as a **nootropic** (cognitive enhancer) but is not an anticholinesterase and is not the first-line treatment for Alzheimer’s. * **D. Gemfibrozil:** This is a **fibrate** used as a hypolipidemic agent. It activates PPAR-α to lower triglyceride levels and has no role in the cholinergic system or Alzheimer’s management. **High-Yield Clinical Pearls for NEET-PG:** * **Rivastigmine:** A "pseudo-irreversible" inhibitor that inhibits both AChE and Butyrylcholinesterase (BuChE). It is available as a **transdermal patch** to reduce GI side effects. * **Galantamine:** Also acts as a **nicotinic receptor modulator**, enhancing the action of acetylcholine. * **Memantine:** An **NMDA receptor antagonist** often used in moderate-to-severe Alzheimer’s, frequently as an adjunct to Donepezil. * **Side Effects:** Common side effects of central AChE inhibitors include "SLUDGE" symptoms (diarrhea, nausea, bradycardia, and insomnia).

Q: All of the following are cholinergic drugs except?

Memantine. **Explanation:** The correct answer is **Memantine** because it belongs to a different pharmacological class than the other options. **1. Why Memantine is the Correct Answer:** Memantine is an **NMDA (N-methyl-D-aspartate) receptor antagonist**. It works by blocking the overstimulation of glutamate receptors, which helps prevent excitotoxicity in neurons. It is not a cholinergic drug and does not directly affect acetylcholine levels. It is primarily used in the management of moderate-to-severe Alzheimer’s disease. **2. Why the other options are incorrect:** * **Tacrine, Rivastigmine, and Donepezil** are all **Centrally acting Reversible Acetylcholinesterase Inhibitors (AChEIs)**. * These drugs inhibit the enzyme that breaks down acetylcholine in the synaptic cleft, thereby increasing cholinergic transmission in the brain. * They are classified as **indirect-acting cholinergic agonists** (parasympathomimetics) and are used to treat mild-to-moderate Alzheimer’s disease. **3. Clinical Pearls for NEET-PG:** * **Tacrine:** The first AChEI approved for Alzheimer's, but now rarely used due to significant **hepatotoxicity**. * **Rivastigmine:** Unique because it inhibits both Acetylcholinesterase and Butyrylcholinesterase. It is available as a **transdermal patch**, which reduces GI side effects. * **Donepezil:** Often preferred due to its long half-life (once-daily dosing) and better tolerability. * **Galantamine:** Another common AChEI used in Alzheimer’s (often tested alongside these options). * **Combination Therapy:** Memantine is frequently combined with Donepezil (e.g., Namzaric) for synergistic effects in advanced dementia.

Q: Which of the following is a naturally occurring tertiary amine and lipid-soluble reversible anticholinesterase?

Physostigmine. ### Explanation The correct answer is **Physostigmine**. **1. Why Physostigmine is correct:** Physostigmine is an alkaloid obtained from the Calabar bean (*Physostigma venenosum*), making it a **naturally occurring** compound. Chemically, it is a **tertiary amine**, which means it lacks a permanent positive charge. This lack of charge makes it highly **lipid-soluble**, allowing it to readily cross the blood-brain barrier (BBB) and exert both peripheral and central effects. It acts as a reversible anticholinesterase by inhibiting the enzyme acetylcholinesterase. **2. Why the other options are incorrect:** * **Neostigmine & Pyridostigmine:** These are **synthetic** compounds, not naturally occurring. Structurally, they are **quaternary ammonium compounds**. Because they carry a permanent positive charge, they are lipid-insoluble and **cannot cross the blood-brain barrier**. Consequently, they lack central nervous system (CNS) activity and are primarily used for peripheral conditions like Myasthenia Gravis or reversing neuromuscular blockade. **3. NEET-PG High-Yield Clinical Pearls:** * **Drug of Choice:** Physostigmine is the specific antidote for **Atropine poisoning** (belladonna poisoning) because it can enter the CNS to reverse central anticholinergic toxicity. * **Glaucoma:** It was historically used topically to treat miotic glaucoma (though largely replaced by newer agents). * **Mnemonic:** Remember **"P"** for Physostigmine = **P**enetrates the CNS (Tertiary). **"N"** for Neostigmine = **N**o CNS entry (Quaternary). * **Side Effects:** Excessive use can lead to a cholinergic crisis (SLUDGE syndrome: Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis).

Q: What is a primary effect of atropine?

Tachycardia. **Explanation:** **Mechanism of Action:** Atropine is a competitive antagonist of muscarinic acetylcholine receptors [4]. In the heart, it specifically blocks the **M2 receptors** located on the Sinoatrial (SA) node. Under normal physiological conditions, the vagus nerve exerts a continuous inhibitory (parasympathetic) tone on the heart. By blocking these M2 receptors, atropine inhibits vagal influence, leading to an increase in heart rate (**Tachycardia**) [2], [3]. This is the primary reason it is used clinically to treat symptomatic bradycardia. **Analysis of Options:** * **Option A (Bradycardia):** While low doses of atropine can occasionally cause transient "paradoxical bradycardia" due to the blockade of presynaptic inhibitory M1 receptors on vagal nerve endings [1], [2], the **primary and therapeutic effect** is tachycardia. * **Option C (Aggravation of heart block):** Atropine actually **improves** atrioventricular (AV) conduction by blocking vagal tone at the AV node [2]. Therefore, it is used to treat certain types of heart block, not aggravate them. * **Option D (Decreased vasomotor tone):** Vasomotor tone is primarily regulated by the sympathetic nervous system (alpha-1 receptors). Since most blood vessels lack functional parasympathetic innervation, atropine has no significant effect on blood pressure or vasomotor tone at standard doses [3]. **High-Yield NEET-PG Pearls:** * **Drug of Choice:** Atropine is the DOC for **Symptomatic Bradycardia** and **Organophosphate Poisoning**. * **Mnemonic for Toxicity:** "Hot as a hare, red as a beet, dry as a bone, blind as a bat, and mad as a hatter." * **Contraindication:** Strictly contraindicated in patients with **Angle-closure Glaucoma** (due to mydriasis) and **Benign Prostatic Hyperplasia (BPH)** (due to urinary retention).

Q: Which of the following is a potent vasoconstrictor?

Epinephrine. **Explanation:** The correct answer is **Epinephrine** because of its potent agonist action on **$\alpha_1$-adrenergic receptors**. While epinephrine acts on $\alpha_1, \alpha_2, \beta_1,$ and $\beta_2$ receptors, its effect on $\alpha_1$ receptors in the vascular smooth muscle leads to significant vasoconstriction, especially in the skin, mucous membranes, and renal vascular beds. At high doses, the $\alpha_1$-mediated vasoconstrictor effect predominates over the $\beta_2$-mediated vasodilation. **Analysis of Incorrect Options:** * **Amphetamines:** These are indirect-acting sympathomimetics that primarily act by releasing stored norepinephrine. While they can increase blood pressure, they are not classified as potent primary vasoconstrictors compared to direct-acting catecholamines like epinephrine. * **Isoprenaline:** This is a **pure $\beta$-agonist** ($\beta_1$ and $\beta_2$). Due to its strong $\beta_2$ action, it causes marked **vasodilation** (decreasing peripheral resistance), making it the opposite of a vasoconstrictor. * **Dobutamine:** This is a relatively selective **$\beta_1$-agonist** used primarily as an inotrope. It has minimal effects on vascular $\alpha_1$ receptors; in fact, it may cause mild vasodilation due to weak $\beta_2$ activity. **NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC):** Epinephrine (1:1000 IM) is the DOC for **Anaphylactic Shock** because it causes vasoconstriction ($\alpha_1$) to relieve mucosal edema/hypotension and bronchodilation ($\beta_2$). * **Vasomotor Reversal of Dale:** If an $\alpha$-blocker (e.g., Phentolamine) is given before Epinephrine, the $\alpha_1$ (vasoconstrictor) effect is blocked, leaving the $\beta_2$ (vasodilator) effect unopposed, leading to a fall in blood pressure. * **Potency:** Norepinephrine is a more "pure" vasoconstrictor than Epinephrine because it lacks significant $\beta_2$ activity.

Q: Which drug possesses antagonistic action at histamine, serotonin, and muscarinic receptors?

Cyproheptadine. **Explanation:** **Cyproheptadine** is a first-generation antihistamine known for its broad pharmacological profile. It acts as a potent antagonist at: 1. **H1 Receptors:** Used to treat allergic conditions. 2. **5-HT2 Receptors:** Its anti-serotonergic property makes it unique; it is the drug of choice for **Serotonin Syndrome** and is used to manage dumping syndrome and post-gastrectomy diarrhea. 3. **Muscarinic Receptors:** It exhibits significant anticholinergic activity, leading to side effects like dry mouth and urinary retention. 4. **Hypothalamic Receptors:** By inhibiting serotonin receptors in the appetite center, it acts as an **appetite stimulant**, often used in children and underweight patients. **Analysis of Incorrect Options:** * **Promethazine:** A first-generation antihistamine with strong sedative, antiemetic, and anticholinergic properties, but it lacks significant serotonin antagonism. * **Terfenadine:** A second-generation antihistamine that is highly selective for H1 receptors. It lacks CNS and anticholinergic effects but was withdrawn globally due to its potential to cause **Torsades de Pointes** (QT prolongation) when co-administered with CYP3A4 inhibitors. * **Hydroxyzine:** A first-generation H1 blocker with significant sedative and anxiolytic properties, but it does not possess the characteristic triple-antagonism (H, 5-HT, M) seen with Cyproheptadine. **High-Yield NEET-PG Pearls:** * **Drug of Choice (DOC):** Cyproheptadine is the DOC for **Serotonin Syndrome**. * **Side Effect Profile:** Like most first-generation antihistamines, it causes sedation and "atropine-like" side effects. * **Clinical Use:** Apart from allergies, it is frequently tested for its role in treating **Cushing's disease** (due to ACTH inhibition) and as an appetite stimulant.

Question 1

Which of the following drugs binds only with the anionic site of cholinesterase?

Accepted Answer

Edrophonium

Answer

Physostigmine

Answer

Neostigmine

Answer

Pyridostigmine

Question 2

Which of the following drugs does not cross the blood-brain barrier?

Accepted Answer

Glycopyrrolate

Answer

Atropine

Answer

Scopolamine

Answer

Promethazine

Question 3

Which of the following is NOT an alpha-adrenoceptor agonist?

Accepted Answer

Isoxsuprine

Answer

Clonidine

Answer

Methyldopa

Answer

Guanabenz

Question 4

Which of the following is a long-acting non-depolarizing competitive blocker?

Accepted Answer

Doxacurium

Answer

Rocuronium

Answer

Mivacurium

Answer

Atracurium

Question 5

Which of the following is a relatively cerebroselective anticholinesterase found to afford symptomatic improvement in Alzheimer's disease?

Accepted Answer

Donepezil

Answer

Pyridostigmine

Answer

Pyritinol

Answer

Gemfibrozil

Question 6

All of the following are cholinergic drugs except?

Accepted Answer

Memantine

Answer

Tacrine

Answer

Rivastigmine

Answer

Donepezil

Question 7

Which of the following is a naturally occurring tertiary amine and lipid-soluble reversible anticholinesterase?

Accepted Answer

Physostigmine

Answer

Neostigmine

Answer

Pyridostigmine

Answer

All of the above

Question 8

What is a primary effect of atropine?

Accepted Answer

Tachycardia

Answer

Bradycardia

Answer

Aggravation of heart block

Answer

Decreased vasomotor tone

Question 9

Which of the following is a potent vasoconstrictor?

Accepted Answer

Epinephrine

Answer

Amphetamines

Answer

Isoprenaline

Answer

Dobutamine

Question 10

Which drug possesses antagonistic action at histamine, serotonin, and muscarinic receptors?

Accepted Answer

Cyproheptadine

Answer

Promethazine

Answer

Terfenadine

Answer

Hydroxyzine

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?